Oxygen Biotherapeutics, Inc., is dedicated to commercializing innovative pharmaceuticals and medical devices in the field of oxygen therapeutics and Defense Medicine™.

The company has under development a perfluorocarbon (PFC) therapeutic oxygen carrier and liquid ventilation product (OXYCYTE®) and has out-licensed an implantable glucose sensor. These products are based upon core technologies that include biomedical applications for PFCs as well as medical and industrial applications for biosensors.

The company believes OXYCYTE has the potential for use in multiple indications, including traumatic brain injury, sickle cell crisis pain, trauma, wound care, decompression sickness, acute respiratory distress syndrome, stroke, myocardial infarction, surgery, diabetes and cosmetic applications.